(R)-N-(2-(2-((4-(4-chlorobenzyl)-1-oxophthalazin-2(1H)-yl)methyl)pyrrolidin-1-yl)ethyl)-4-methoxy-N-methylbutanamide Trifluoroacetate

ID: ALA5284242

Chembl Id: CHEMBL5284242

Max Phase: Preclinical

Molecular Formula: C30H36ClF3N4O5

Molecular Weight: 511.07

Associated Items:

Names and Identifiers

Canonical SMILES:  COCCCC(=O)N(C)CCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C28H35ClN4O3.C2HF3O2/c1-31(27(34)10-6-18-36-2)16-17-32-15-5-7-23(32)20-33-28(35)25-9-4-3-8-24(25)26(30-33)19-21-11-13-22(29)14-12-21;3-2(4,5)1(6)7/h3-4,8-9,11-14,23H,5-7,10,15-20H2,1-2H3;(H,6,7)/t23-;/m1./s1

Standard InChI Key:  FKEYBQUXJBIQQC-GNAFDRTKSA-N

Associated Targets(Human)

HRH1 Tclin Histamine H1 receptor (7573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1B Tclin Alpha-1b adrenergic receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 511.07Molecular Weight (Monoisotopic): 510.2398AlogP: 3.99#Rotatable Bonds: 11
Polar Surface Area: 67.67Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.50CX LogP: 3.58CX LogD: 3.23
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.36Np Likeness Score: -1.30

References

1. Procopiou PA, Ford AJ, Gore PM, Looker BE, Hodgson ST, Holmes DS, Vile S, Clark KL, Saunders KA, Slack RJ, Rowedder JE, Watts CJ..  (2017)  Design of Phthalazinone Amide Histamine H1 Receptor Antagonists for Use in Rhinitis.,  (5): [PMID:28523114] [10.1021/acsmedchemlett.7b00112]

Source